BSX INVESTOR ALERT: Boston Scientific Corporation Investors

NodeGuardian · 2026-03-22T20:38:37+00:00

Robbins Geller Rudman & Dowd LLP filed a class action lawsuit against Boston Scientific for misleading investors about its revenue and growth in the Electrophysiology market, affecting those who suffered losses between July 2025 and February 2026.

NodeGuardian

2026-03-22 20:38:37

Abstract generation in progress

Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit against Boston Scientific Corporation (NYSE: BSX) for investors who suffered substantial losses between July 23, 2025, and February 3, 2026. The lawsuit, captioned Troike v. Boston Scientific Corporation, alleges that the company made misleading statements regarding its revenue outlook, growth projections, and competitive position in the Electrophysiology market. Investors have until May 4, 2026, to seek appointment as lead plaintiff.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes